HEPATOCYTE NUCLEAR FACTOR-1α INHIBITS INSULIN PROMOTER FACTOR 1-DEPENDENT TRANSACTIVATION OF THE HUMAN INSULIN GENE

2001 ◽  
Vol 27 (1-2) ◽  
pp. 63-74 ◽  
Author(s):  
Kenichi Yamakawa ◽  
Hironori Yamasaki ◽  
Masako Ozaki ◽  
Mikako-Degawa Yamauchi ◽  
Naruhiro Fujita ◽  
...  
1999 ◽  
Vol 263 (2) ◽  
pp. 566-569 ◽  
Author(s):  
Kohei Okita ◽  
Qin Yang ◽  
Kazuya Yamagata ◽  
Kerstin A. Hangenfeldt ◽  
Jun-ichiro Miyagawa ◽  
...  

1989 ◽  
Vol 264 (1) ◽  
pp. 233-239 ◽  
Author(s):  
D S W Boam ◽  
K Docherty

Sequence-specific binding of proteins from an insulin-secreting cell line (RINm-5F) to the human insulin-gene 5′ region were examined by gel-retardation and methylation-interference analysis. Specific binding of a nuclear factor to sites between nucleotides -210 to -217 and -77 to -84 was detected. The same binding activity was shown at an upstream site (-313 to -320) with low affinity. Studies using mutated binding-site probes delineated a sequence 5′-C(T/C)CTAATG-3′ for high-affinity interactions. This binding activity was also present in another insulin-producing cell line (HIT.T15), but not in extracts from cell lines that did not express the insulin gene (HeLa, HL60). Cross-species comparisons show that this sequence element is highly conserved and may thus play an important role in the cell-specific regulation of insulin-gene transcription.


2005 ◽  
Vol 19 (5) ◽  
pp. 1343-1360 ◽  
Author(s):  
Maria F. Pino ◽  
Diana Z. Ye ◽  
Katrina D. Linning ◽  
Christopher D. Green ◽  
Barton Wicksteed ◽  
...  

2007 ◽  
Vol 53 (2) ◽  
pp. 189-200 ◽  
Author(s):  
Masahito WATANABE ◽  
Kazuhiro UMEYAMA ◽  
Hiro-omi KAWANO ◽  
Naoko IZUNO ◽  
Hiroshi NAGASHIMA ◽  
...  

2007 ◽  
Vol 192 (1) ◽  
pp. 141-147 ◽  
Author(s):  
Sachiko Kitanaka ◽  
Utako Sato ◽  
Takashi Igarashi

Mutations in hepatocyte nuclear factor-1β (HNF-1β) lead to type 5 maturity-onset diabetes of the young (MODY5). Moreover, mutations in the HNF-1β gene might cause multiorgan abnormalities including renal diseases, genital malformations, and abnormal liver function. The objective of this study was to investigate the molecular mechanism of diabetes mellitus, intrauterine growth retardation, and cholestasis observed in MODY5 patients. We analyzed the transactivity of wild-type and three mutant HNF-1β on native human insulin, IGF-I, and multidrug resistance protein 2 (MRP2) promoters in combination with HNF-1α, using a reporter-assay system in transiently transfected mammalian cells. In the human insulin gene promoter, we found that the cooperation of HNF-1α and HNF-1β is prominent. Absence of this cooperation was observed in all of the HNF-1β mutants. In the human IGF-I and MRP2 promoters, we found that the HNF-1β His153Asn (H153N) mutant had a mutant-specific repressive effect on both HNF-1α and wild-type HNF-1β transactivity. Absence of the cooperation of HNF-1β mutants with HNF-1α in the human insulin gene promoter might be one cause of defective insulin secretion. The H153N mutant-specific repression of HNF-1α and HNF-1β transactivity in human IGF-I and MRP2 promoters might explain the case-specific clinical features of growth retardation and cholestasis observed only in early infancy. We found differential property of HNF-1α/HNF-1β activity and the effect of HNF-1β mutants by the promoters. We consider that analyses of HNF-1β mutants on the intended human native promoters in combination with HNF-1α may be useful in investigating the molecular mechanisms of the various features in MODY5.


1993 ◽  
Vol 21 (7) ◽  
pp. 1595-1600 ◽  
Author(s):  
Louise Reibel ◽  
Corinne Besnard ◽  
Patrick Lores ◽  
Jacques Jami ◽  
Gerard Gacon

Diabetes ◽  
1985 ◽  
Vol 34 (5) ◽  
pp. 433-439 ◽  
Author(s):  
S. Elbein ◽  
P. Rotwein ◽  
M. A. Permutt ◽  
G. I. Bell ◽  
N. Sanz ◽  
...  

Author(s):  
Rafid A. Abdulkareem

The main goal of the current study was cloning and expression of the human insulin gene in Pichia pastoris expression system, using genetic engineering techniques and its treatment application. Total RNA was purified from fresh normal human pancreatic tissue. RNA of good quality was chosen to obtain a first single strand cDNA. Human preproinsulin gene was amplified from cDNA strand, by using two sets of specific primers contain EcoR1 and Notl restriction sites. The amplified preproinsulin gene fragment was double digested with EcoRI and Not 1 restriction enzymes, then inserted into pPIC9K expression vector. The new pPIC9K-hpi constructive expression vector was transformed by the heat-shock method into the E.coli DH5α competent cells. pPic9k –hpi, which was propagated in the positive transformant E. coli cells, was isolated from cells and then linearised by restriction enzyme SalI, then transformed into Pichia pastoris GS115 using electroporation method. Genomic DNA of His+ transformants cell was extracted and used as a template for PCR analysis. The results showed, that the pPic9k – hpi was successfully integrated into the P. pastoris genome, for selected His+ transformants clones on the anticipated band at 330 bp, which is corresponded to the theoretical molecular size of the human insulin gene. To follow the insulin expression in transformans, Tricine–SDS gel electrophoresis and Western blot analysis were conducted. The results showed a successful expression of recombinant protein was detected by the presence of a single major band with about (5.8 KDa) on the gel. These bands correspond well with the size of human insulin with the theoretical molecular weight (5.8 KDa).


1982 ◽  
Vol 10 (7) ◽  
pp. 2225-2240 ◽  
Author(s):  
Axel Ullrich ◽  
Thomas J. Dull ◽  
Alane Gray ◽  
John A. Philips ◽  
Stephan Peter

Sign in / Sign up

Export Citation Format

Share Document